Filing Flows › Comparisons › MMM vs BSX
3M vs Boston Scientific: MMM and BSX compared
3M is the larger company: $6.6B of revenue in its latest quarter (Q3 2026) against $5.1B for Boston Scientific (Q3 2026). Boston Scientific is growing faster (+1% against +1% a year earlier). 3M is more profitable, with an operating margin of 23.7% against 16.1%.
Where the money goes: MMM and BSX
3M (MMM) · Q3 2026
3M, Q3 2026: revenue $6.6B (+1% year over year), operating margin 23.7%, net earnings $1.4B, operating cash flow $486M. The chart follows the revenue to costs, profit and cash.
Boston Scientific (BSX) · Q3 2026
Boston Scientific, Q3 2026: revenue $5.1B (+1% year over year), operating margin 16.1%, net earnings $580M, operating cash flow $1.0B. The chart follows the revenue to costs, profit and cash.
| 3M (MMM) | Boston Scientific (BSX) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $6.6B | $5.1B |
| Revenue growth, Y/Y | +1% | +1% |
| Gross margin | — | 66.7% |
| Operating margin | 23.7% | 16.1% |
| Net earnings | $1.4B | $580M |
| Net margin | 20.9% | 11.3% |
| Operating cash flow | $486M | $1.0B |
| Free cash flow | $230M | $868M |
| Market value | $98.1B | $64.8B |
| P/E | 28.0× | 18.9× |
| Analysts’ mean target | $194.51 | $49.60 |
Where the revenue comes from
Boston Scientific
- Interventional Cardiology & Vascular Therapies: $1.3B (25%)
- Electrophysiology: $816M (16%)
- Endoscopy: $741M (14%)
- Urology: $661M (13%)
Questions
Which is bigger, 3M or Boston Scientific?
3M is the larger company: $6.6B of revenue in its latest quarter (Q3 2026) against $5.1B for Boston Scientific (Q3 2026).
Is 3M or Boston Scientific growing faster?
Boston Scientific is growing faster (+1% against +1% a year earlier).
Which is more profitable, 3M or Boston Scientific?
3M is more profitable, with an operating margin of 23.7% against 16.1%.
More: 3M earnings · how 3M makes money · Boston Scientific earnings · how Boston Scientific makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 20, 2026; 10-Q filed Nov 2, 2026). Fiscal quarters can end on different dates. Not investment advice.